Saving women's lives : strategies for improving breast cancer detection and diagnosis : a Breast Cancer Research Foundation and Institute of Medicine Symposium

In the afternoon, panelists from the National Cancer Institute, the Food and Drug Administration, Kaiser Permanente, Blue Cross Blue Shield, the American College of Radiology (ACR), Partners Health Care, and University of California, San Francisco, gave presentations and participated in discussions...

Full description

Main Author: Herdman, Roger
Corporate Authors: Institute of Medicine (U.S.), National Cancer Policy Board (U.S.) Committee on New Approaches to Early Detection and Diagnosis of Breast Cancer
Other Authors: Norton, Larry
Format: eBook
Language:English
Published: Washington, DC National Academies Press c2005, 2005
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 03522nam a2200349 u 4500
001 EB000943275
003 EBX01000000000000000736865
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
020 |a 0309546311 
020 |a 0309094380 
100 1 |a Herdman, Roger 
245 0 0 |a Saving women's lives  |h Elektronische Ressource  |b strategies for improving breast cancer detection and diagnosis : a Breast Cancer Research Foundation and Institute of Medicine Symposium  |c Committee on New Approaches to Early Detection and Diagnosis of Breast Cancer, National Cancer Policy Board, Roger Herdman and Larry Norton, editors ; Institute of Medicine and National Research Council of the National Academies 
260 |a Washington, DC  |b National Academies Press  |c c2005, 2005 
300 |a 1 PDF file (ix, 134 p.  |b ill.) 
505 0 |a Includes bibliographical references 
653 |a Research 
653 |a Mass Screening 
653 |a Mammography 
653 |a Breast Neoplasms / diagnosis 
700 1 |a Norton, Larry 
710 2 |a Institute of Medicine (U.S.) 
710 2 |a National Cancer Policy Board (U.S.)  |b Committee on New Approaches to Early Detection and Diagnosis of Breast Cancer 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
856 |u https://www.ncbi.nlm.nih.gov/books/NBK83867  |3 Volltext 
082 0 |a 610 
520 |a In the afternoon, panelists from the National Cancer Institute, the Food and Drug Administration, Kaiser Permanente, Blue Cross Blue Shield, the American College of Radiology (ACR), Partners Health Care, and University of California, San Francisco, gave presentations and participated in discussions with attendees in two groups, one on delivering better breast cancer screening services and one on developing and delivering new detection technologies.  
520 |a In this report The Breast Cancer Research Foundation (BCRF) and the Institute of Medicine (IOM) present a one-day symposium that was held at the IOM to further disseminate the conclusions and recommendations of the joint IOM and National Research Council report, Saving Women's Lives: Strategies for Improving Breast Cancer Detection and Diagnosis. The symposium was introduced by Mrs. Evelyn Lauder, Founder and Chairman of the BCRF; and Dr. Edward Penhoet, Chairman of the IOM committee for the report. At a plenary session in the morning six invited experts from academia, the American Cancer Society, and the Centers for Medicare and Medicaid Services gave presentations on what women need to know about mammography, challenges to expanding mammography capacity, better models for mammography services, risk stratification for breast cancer detection, the promise of biomarkers, and bringing new technologies into service.  
520 |a A wrap-up session at the end summarized the issues raised, including: how to organize mammography better and recruit women to screening; lessons learned from screening in the United Kingdom; and disparities in breast cancer screening and care, Mammography Quality Standards Act enforcement, ACR perspectives on screening, the roles of National Institutes of Health in cancer detection technology development, engineers working with clinicians to develop breast cancer detection, technology evaluation and coverage policy, and assessing technologies in managed care systems. At the end, a representative of breast cancer survivors gave her perspectives on the day